Study: Flublok is more effective than traditional flu shot

Protein Sciences released data showing that Flublok Quadrivalent--its follow-up to the FDA-approved trivalent Flublok--outperformed the traditional egg-based quadrivalent vaccine. The study involved approximately 9,000 subjects aged 50 or older, half of whom were given Flublok Quadrivalent. The other have received an egg-based vaccine. The results show 31% more people were protected by Flublok than by the traditional vaccine. Release

Suggested Articles

Daiichi Sankyo says it still unable to fulfill a government mandate to be able to produce enough H5N1 flu vaccine to fight an epidemic in Japan.

GSK’s Shingrix has continuously impressed industry watchers with its growth, and the company just added another large market to its list: China.

WuXi Biologics says it will build a dedicated facility to manufacture a commercial vaccine product for a client in a $3 billion contract.